Form 4: Veracyte Director Sells Shares
Insider Transaction (Form 4)
Karin Eastham, a Director of Veracyte, Inc., sold 14,850 shares of common stock on October 27, 2026 for $50.00 per share.
Summary
- Option exercise/conversion: acquired 10,000 Common Stock at $27.01 ($270,100) on October 27, 2026; holds 25,097 after (Direct).
- Open-market sale: disposed of 14,850 Common Stock at $50.00 ($742,573) on October 27, 2026; holds 10,247 after (Direct).
- Option exercise/conversion: disposed of 10,000 Stock Option (right to buy) on October 27, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $742,573 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Karin Eastham — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-27 | Option exercise/conversion | Common Stock | 10,000 | $27 | $270.1K | 25,097 |
| 2026-10-27 | Open-market sale | Common Stock | 14,850 | $50 | $742.6K | 10,247 |
| 2026-10-27 | Option exercise/conversion | Stock Option (right to buy) | 10,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-27 | Option exercise/conversion (10,000 shares) |
| 2026-10-27 | Open-market sale (14,850 shares) |
| 2026-10-27 | Option exercise/conversion (10,000 shares) |
Keywords
insider transaction, Form 4, VCYT, VERACYTE, INC., bearish, Karin Eastham
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.